Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accomplish, affirmative, animal, antiangiogenic, attack, Avastin, Bayer, Biologic, Canada, cardiac, Christensen, colorectal, constituted, deducting, distinct, endothelial, fact, factor, franchise, full, Genentech, Gustav, IND, inhibitor, Israel, lung, Mab, manner, matrix, metalloproteinase, mg, moderate, monotherapy, Nexavar, objective, Optimize, owner, pancreatic, pathway, progression, prostate, protease, proxy, pursuing, randomized, recruiting, refused, renal, satisfaction, SC, shown, solid, suffering, timeline, toxicology, underwriting, vascular, VEGF
Removed:
academic, asterisk, beneficiary, cancer, cell, commercialized, confidential, Consolidation, diagnostic, entity, extent, fight, fluctuate, forward, generating, imaging, inflammation, inhibiting, long, maintain, maintenance, marked, monthly, omitted, patent, proliferation, represent, Summary, surface, target, ultimately, underway, vary, vessel
Filing tables
Filing exhibits
Related press release
DYAX similar filings
Filing view
External links